Product | CAS / Strength | Indication / FDF, Brand / Originator | |
| 贝美前列素, Bimatoprost API DMF in CN，202510 | 155206-00-1 | Antiglaucoma / Allergan | |
| 原研FDF, Bimatoprost Eye Drops | 0.03%, 0.9mg: 3mL | Antiglaucoma / Lumigan / Allergan | |
| 原研FDF, Bimatoprost Ophthalmic Solution (Topical) | 0.03%, 0.9mg: 3mL | Eyelash growth / Latisse / Allergan | |
| 原研FDF, Bimatoprost and Timolol Maleate Eye Drops | 0.9mg Bim and 15mg Tim: 3mL | Antiglaucoma / Ganfort / Allergan | |
| 原研FDF, Bimatoprost Ophthalmic Implant | 10μg | Antiglaucoma / Durysta / Abbvie | |
| 原研FDF, Triple Fixed-Combination, Bim / Bri / Tim | 0.5mg Bim, 7.5mg Bri, 25mg Tim: 5mL | Antiglaucoma / Triplenex / Allergan | |
| 拉坦前列素, Latanoprost API | 130209-82-4 | Antiglaucoma / Pfizer, Bausch | |
| 原研FDF, Latanoprost Eye Drops | 0.005%, 125µg: 2.5mL | Antiglaucoma / Xalatan / Pfizer | |
| 原研FDF, Latanoprost and Timolol Maleate Eye Drops | 0.125mg Lat and 12.5mg Tim: 2.5mL | Antiglaucoma / Xalacom / Pfizer | |
| 原研FDF, Latanoprostene Bunod Ophthalmic Solution | 0.024%：2.5 mL/5 mL | Antiglaucoma / Vyzulta / Bausch and Lomb | |
| 原研FDF, Netarsudil Dimesylate and Latanoprost Ophthalmic Solution | 0.02% Net and 0.005% Lat: 2.5mL | Antiglaucoma / Rocklatan / Alcon | |
| 曲前列尼尔, Treprostinil API | 81846-19-7 | Pulmonary arterial hypertension / United Therapeutics | |
| 原研FDF, Treprostinil Injection | 20mg/50mg/100mg/200mg: 20mL | Pulmonary arterial hypertension / Remodulin / United Therapeutics | |
| 原研FDF, Treprostinil Inhalation Solution | 0.6mg/mL, 1.74 mg: 2.9 mL | Pulmonary arterial hypertension / Tyvaso / United Therapeutics | |
| 原研FDF, Treprostinil Inhalation Powder | 0.016mg, 0.032mg, 0.048mg, 0.064mg | Pulmonary arterial hypertension / Tyvaso DPI / United Therapeutics | |
| 伊洛前列素, Iloprost API | 73873-87-7 | Pulmonary arterial hypertension / Actelion, Bayer | |
| 原研FDF, Iloprost Solution for Infusion | 1mL: 20μg, 0.5mL: 50μg | Pulmonary arterial hypertension / Ilomedin / Bayer | |
| 原研FDF, Iloprost Solution for Inhalation | 2mL: 20μg | Pulmonary arterial hypertension / Ventavis / Bayer | |
| 卡前列素氨丁三醇, CarboprostTromethamine API | 58551-69-2 | Obstetric drugs / Pfizer | |
| 原研FDF, Carboprost Tromethamine Injection | 250µg: 1mL | Obstetric drugs / Hemabate / Pfizer | |
| 地诺前列酮，Dinoprostone API | 363-24-6 | Obstetric drugs / Forest | |
| 原研FDF, Dinoprostone Suppositories | 10mg | Obstetric drugs / Propess / Ferring Pharma | |
| 原研FDF, Dinoprostone Gel | 1mg/3g, 2mg/3g | Obstetric drugs / Prostin® E2 / Pfizer | |
| 前列地尔, Alprostadil API | 745-65-3 | Vasodilator / Pfizer | |
| 原研FDF, Alprostadil for Injection | 5, 10, 20, 40μg/VIAL | Erectile dysfunction / Caverject / Pfizer | |
| 原研FDF, Alprostadil for Injection | 10, 20μg/VIAL | Eerectile dysfunction / Caverject Impulse / Pfizer | |
| 原研FDF, Alprostadil for Injection | 0.5μg/VIAL | PROSTIN VR PEDIATRIC / Pfizer | |
| 原研FDF, Alprostadil for Injection | 10, 20, 40μg/VIAL | Erectile dysfunction / Edex / ENDO OPERATIONS | |
| 贝前列素钠, Beraprost Sodium API | 88475-69-8 | Antithrombotic / Toray, Astellas | |
原料药产品目录 Catalog of APl Products
创新药研发 pipeline of New Drug Innovation
适应症 Indication | 项目编号 Project Code | 作用机制 Mechanism of Action | 早期研发 Early Stage | 临床前研究 Pre-Clinical | 临床试验 Clinical Trial | |
眼科疾病 Ophthalmological Disease | 青光眼 Glaucoma | KRM2306 | Fixed-Combination with a PGF2a prodrug | |||
呼吸系统疾病 Respiratory Disease | 肺动脉高压 Pulmonary Hypertension | KRM2104 | Fixed-Combination with a PGI2 prodrug | |||
皮肤科 Dermatologic Disease | 毛发医美 Hair Restoration and Aesthetics | KRM2101g | Fixed- Combination with Bimatoprost | |||
外周血管疾病 Peripheral Vascular Disease | 糖尿病足 Diabetics Foot | KRM2124c1 | Fixed-Combination with a PGE prodrug | |||
妇产科疾病 Obstetricaland Gynecological Disease | 女性性功能唤起障碍 Female Sexual Arousal Disorder | KRM2204b6 | Fixed-Combination with a PGE prodrug | |||
|
|